International collaborative partnership for the study of atrial fibrillation (INTERAF): Rationale, design, and initial descriptives

Journal of the American Heart Association

Volumn 5, Issue 11, 2016, Pages

  Hsu, Jonathan C ^a   Akao, Masaharu ^b   Abe, Mitsuru ^b,c   Anderson, Karen L ^d   Avezum, Alvaro ^e   Glusenkamp, Nathan ^d   Kohsaka, Shun ^f   Lane, Deirdre A ^g   Lip, Gregory Y H ^g,h   Ma, Chang Sheng ⁱ   Masoudi, Frederick A ^j,k   Potpara, Tatjana S ^l   Siong, Teo Wee ^m   Turakhia, Mintu P ^n,o   Tse, Hung Fat ^p   Rumsfeld, John S ^d,j,k   Maddox, Thomas M ^j,k,q  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c Kanai Hospital   (Japan)

^d AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^e INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^f KEIO UNIVERSITY   (Japan)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h AALBORG UNIVERSITY   (Denmark)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^k Colorado Cardiovascular Outcomes Research ^*  (United States)

^l UNIVERSITY OF BELGRADE   (Serbia)

^m Chee Heart Specialist Clinic   (Singapore)

ⁿ VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^o STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF HONG KONG   (Hong Kong)

^q VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Atrial fibrillation; Clinical registries; Global health; Quality of care and outcomes

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DABIGATRAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTERIAL THROMBOEMBOLISM; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DEMENTIA; DISEASE REGISTRY; HEART FAILURE; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; PAROXYSMAL ATRIAL FIBRILLATION; PERMANENT ATRIAL FIBRILLATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOSIS PREVENTION; DISEASE MANAGEMENT; HEART MUSCLE REVASCULARIZATION; INTERNATIONAL COOPERATION; METHODOLOGY; REGISTER; STANDARDS;

ATRIAL FIBRILLATION; DISEASE MANAGEMENT; HUMANS; INTERNATIONAL COOPERATION; MYOCARDIAL REVASCULARIZATION; REGISTRIES; RESEARCH DESIGN;

EID: 84995532856     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004037     Document Type: Article

References (45)

1. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11:639-654.
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2014;64:2246-2280.
3. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, Zhu J, Jansky P, Sigamani A, Morillo CA, Liu L, Damasceno A, Grinvalds A, Nakamya J, Reilly PA, Keltai K, Van Gelder IC, Yusufali AH, Watanabe E, Wallentin L, Connolly SJ, Yusuf S; on behalf of the RELYAFRI. Variations in cause and management of atrial fibrillation in a prospective registry of 15 400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014;129:1568-1576.
4. Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Davenport RL, Girgus M, Fonarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rosamond W, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW; on behalf of the American Heart Association Advocacy Coordinating C. The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011;123:2167-2179.
5. Lip GYH, Al-Khatib SM, Cosio FG, Banerjee A, Savelieva I, Ruskin J, Blendea D, Nattel S, De Bono J, Conroy JM, Hess PL, Guasch E, Halperin JL, Kirchhof P, Cosio MD, Camm AJ. Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? J Am Heart Assoc. 2014;3:e001179 doi: 10.1161/JAHA.114.001179.
6. Smith MD; Institute of Medicine. Committee on the Learning Health Care System in A. Best Care at Lower Cost the Path to Continuously Learning Health Care in America. Washington, DC: National Academies Press; 2012.
7. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJL. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837-847.
8. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
9. Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063-2066.
10. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-484.
11. Udompanich S, Lip GYH, Apostolakis S, Lane DA. Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM. 2013;106:795-802.
12. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna W, Seward JB, Iwasaka T, Tsang TSM. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J. 2006;27:936-941.
13. Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012;172:1386-1394.
14. Kawabata-Yoshihara LA, Scazufca M, Santos Ide S, Whitaker A, Kawabata VS, Bensenor IM, Menezes PR, Lotufo PA. Atrial fibrillation and dementia: results from the Sao Paulo ageing & health study. Arq Bras Cardiol. 2012;99:1108-1114.
15. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127:569-574.
16. Uchiyama S, Shibata Y, Hirabayashi T, Mihara B, Hamashige N, Kitagawa K, Goto S, Origasa H, Shimada K, Kobayashi H, Isozaki M, Ikeda Y. Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry. J Stroke Cerebrovasc Dis. 2010;19:190-197.
17. Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau C-S, Hirsch AT, Mas J-L, Wilson PWF, Corbalán R, Aichner F, Steg PG. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008;156:855-863.e852.
18. Liu Y, Liu H, Dong L, Chen J, Guo J. Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University. Acta Cardiol. 2010;65:221-224.
19. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107.
20. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009;158:629-636.
21. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey J-Y, Prins MH, Lévy S, Crijns HJGM; European Heart Survey I. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422-2434.
22. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. The registry of the German competence network on atrial fibrillation: patient characteristics and initial management. Europace. 2008;11:423-434.
23. Zhang S. Atrial fibrillation in mainland China: epidemiology and current management. Heart. 2009;95:1052-1055.
24. Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol. 2008;52:865-868.
25. Chen Y-H, Chen H, Wu Y, Hu D. Cardiac electrophysiology in China. Heart Rhythm. 2007;4:862.
26. Dewhurst MJ, Adams PC, Gray WK, Dewhurst F, Orega GP, Chaote P, Walker RW. Strikingly low prevalence of atrial fibrillation in elderly Tanzanians. J Am Geriatr Soc. 2012;60:1135-1140.
27. Shavadia J, Yonga G, Mwanzi S, Jinah A, Moriasi A, Otieno H. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi: cardiovascular topics. Cardiovasc J Afr. 2013;24:6-9.
28. Kakkar AK, Mueller I, Bassand J-P, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GYH, Mantovani LG, Turpie AGG, van Eickels M, Misselwitz F, Rushton-Smith S, Kayani G, Wilkinson P, Verheugt FWA; for the GRI. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013;8:e63479.
29. Hori M, Connolly SJ, Zhu J, Liu LS, Lau CP, Pais P, Xavier D, Kim SS, Omar R, Dans AL, Tan RS, Chen JH, Tanomsup S, Watanabe M, Koyanagi M, Ezekowitz MD, Reilly PA, Wallentin L, Yusuf S; the RELYI. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke. 2013;44:1891-1896.
30. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H; Investigators JRR. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J. 2011;75:1328-1333.
31. Suzuki S, Yamashita T, Kato T, Fujino T, Sagara K, Sawada H, Aizawa T, Fu L-T. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J. 2007;71:761-765.
32. Shen AY-J, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50:309-315.
33. Pollack CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Jr, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam C-W, Weitz JI. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511-520.
34. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; Investigators PA. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534-542.
35. Masoudi FA, Calkins H, Kavinsky CJ, Drozda JP, Gainsley P, Slotwiner DJ, Turi ZG. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview. J Am Coll Cardiol. 2015;66:1497-1513.
36. Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21:578-582.
37. Go AS, Magid DJ, Wells B, Sung SH, Cassidy-Bushrow AE, Greenlee RT, Langer RD, Lieu TA, Margolis KL, Masoudi FA, McNeal CJ, Murata GH, Newton KM, Novotny R, Reynolds K, Roblin DW, Smith DH, Vupputuri S, White RE, Olson J, Rumsfeld JS, Gurwitz JH. The cardiovascular research network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008;1:138-147.
38. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, Lopez-Sendon J, Vardas PE, Aliot E, Santini M, Crijns HJ. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2006;27:3018-3026.
39. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Verheugt FW, Jamal W, Misselwitz F, Rushton-Smith S, Turpie AG. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012;163:13-19.e11.
40. Huisman MV, Lip GY, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Teutsch C, Zint K, Ackermann D, Clemens A, Bartels DB. Design and rationale of global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Am Heart J. 2014;167:329-334.
41. Alam M, Bandeali SJ, Shahzad SA, Lakkis N. Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry. Expert Rev Cardiovasc Ther. 2012;10:283-291.
42. Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W. Real-life observations of clinical outcomes with rhythm-and rate-control therapies for atrial fibrillation RECORDAF (registry on cardiac rhythm disorders assessing the control of atrial fibrillation). J Am Coll Cardiol. 2011;58:493-501.
43. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP. 'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med. 2014;127:519-529.e511.
44. Inohara T, Kohsaka S, Miyata H, Ueda I, Maekawa Y, Fukuda K, Cohen DJ, Kennedy KF, Rumsfeld JS, Spertus JA. Performance and validation of the U.S. NCDR acute kidney injury prediction model in Japan. J Am Coll Cardiol. 2016;67:1715-1722.
45. Kohsaka S, Miyata H, Ueda I, Masoudi FA, Peterson ED, Maekawa Y, Kawamura A, Fukuda K, Roe MT, Rumsfeld JS. An international comparison of patients undergoing percutaneous coronary intervention: a collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio Interhospital Cardiovascular Studies (JCD-KICS). Am Heart J. 2015;170:1077-1085.